Novel therapies for cyclic GMP control of vascular smooth muscle growth
about
The cyclic GMP modulators YC-1 and zaprinast reduce vessel remodeling through antiproliferative and proapoptotic effects.The dopamine D3 receptor knockout mouse mimics aging-related changes in autonomic function and cardiac fibrosisPhosphodiesterases Regulate BAY 41-2272-Induced VASP Phosphorylation in Vascular Smooth Muscle Cells.Inhibition of vascular smooth muscle growth via signaling crosstalk between AMP-activated protein kinase and cAMP-dependent protein kinase.Antigrowth properties of BAY 41-2272 in vascular smooth muscle cells.Adrenoreceptors and nitric oxide in the cardiovascular system.Novel protein kinase targets in vascular smooth muscle therapeutics.Soluble guanylyl cyclase-activated cyclic GMP-dependent protein kinase inhibits arterial smooth muscle cell migration independent of VASP-serine 239 phosphorylation.Cyclic Nucleotide-Directed Protein Kinases in Cardiovascular Inflammation and Growth.The vasodilatory effect of sulfur dioxide via SGC/cGMP/PKG pathway in association with sulfhydryl-dependent dimerization.
P2860
Q34973860-2EB2FD8D-1367-46DB-9249-AE350733EB08Q34983783-5B93572B-8A1C-4BF3-9F82-A842B6509A68Q35740400-8A785B9B-C375-4E57-9B61-69DE55305FC8Q36352070-3C8234C5-F238-435C-8B78-A9FED09DDA42Q37193830-B886BD6B-EA35-4F81-A304-4FB8BB6FE5B1Q38162217-DF453BD3-F3A9-45DB-81F8-06617AB11B97Q39226961-10259BA3-C568-431B-8274-A5C0FE9938CDQ41869044-A638AE49-9433-462C-9CC8-2B9337BB8F28Q47713533-9C9B34B2-6604-4AD2-99E9-07AB653597DDQ55026322-C93DFEDB-9E4C-4777-A5F4-9FF95BA8EA31
P2860
Novel therapies for cyclic GMP control of vascular smooth muscle growth
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Novel therapies for cyclic GMP control of vascular smooth muscle growth
@en
Novel therapies for cyclic GMP control of vascular smooth muscle growth.
@nl
type
label
Novel therapies for cyclic GMP control of vascular smooth muscle growth
@en
Novel therapies for cyclic GMP control of vascular smooth muscle growth.
@nl
prefLabel
Novel therapies for cyclic GMP control of vascular smooth muscle growth
@en
Novel therapies for cyclic GMP control of vascular smooth muscle growth.
@nl
P2860
P1476
Novel therapies for cyclic GMP control of vascular smooth muscle growth
@en
P2093
David A Tulis
P2860
P304
P356
10.1097/MJT.0B013E318140052F
P577
2008-11-01T00:00:00Z